Meanwhile, results of immunochemistry assays obtained from the public database The Human Protein Atlas (https://www.proteinatlas.org/) showed that RAB3D was expressed at much higher levels in glioma tissues than in adjacent non-tumor tissues (P < 0.05, Figure 7H). This evidence concerns the gene RAB3D and central nervous system cancer.